Contract Pharma Staff06.04.20
Tedor Pharma and Cardinal Health Regulatory Sciences have formed a collaboration to deliver integrated regulatory solutions to meet the needs of the evolving manufacturing compliance environment in the biopharmaceutical industry.
The agreement leverages the regulatory consulting expertise of Cardinal Health and Tedor’s oral solid dose manufacturing capabilities and exclusive North American drug delivery technologies.
"Bringing together the deep industry expertise of Cardinal Health Regulatory Sciences with Tedor’s collaborative approach in contract development and manufacturing will be transformative for our clients,” said Doug Drysdale, president and chief executive officer, Tedor.
The agreement leverages the regulatory consulting expertise of Cardinal Health and Tedor’s oral solid dose manufacturing capabilities and exclusive North American drug delivery technologies.
"Bringing together the deep industry expertise of Cardinal Health Regulatory Sciences with Tedor’s collaborative approach in contract development and manufacturing will be transformative for our clients,” said Doug Drysdale, president and chief executive officer, Tedor.